CHE · 10-Q · 2026Q1 · Full report
VITAS continuous care decline
CHEMED CORP · 2026-04-28 · Importance 61 · Surprise 66
VITAS continuous care net revenue declined 26.4% in Q1 2026 to $18.1 million from $24.6 million in Q1 2025. Continuous care days fell 23.6% year-over-year to 17,288 days in Q1 2026, reducing continuous-care contribution to total days and revenue mix. Continuous care represented 4.2% of VITAS net revenue in Q1 2026 versus 5.9% in Q1 2025, lowering average revenue per day mix and partially offsetting routine homecare gains. These declines occurred while total VITAS days-of-care increased 2.2% year-over-year, underscoring a significant service-level mix shift in the quarter.
Key facts
- VITAS continuous care revenue for the three months ended March 31, 2026: $18,133 thousand, down 26.4% versus $24,637 thousand in prior year
- VITAS continuous care days for the three months ended March 31, 2026: 17,288 days (23.6% decrease versus 22,620 prior year)
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | realized | -1.0% | VITAS continuous care revenue for the three months ended March 31, 2026: $18,133 thousand, down 26.4% versus $24,637 thousand in prior year |